vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and Planet Labs PBC (PL). Click either name above to swap in a different company.

Core Laboratories Inc. is the larger business by last-quarter revenue ($121.8M vs $81.3M, roughly 1.5× Planet Labs PBC). Core Laboratories Inc. runs the higher net margin — 4.2% vs -72.8%, a 77.1% gap on every dollar of revenue. On growth, Planet Labs PBC posted the faster year-over-year revenue change (32.6% vs -1.4%). Planet Labs PBC produced more free cash flow last quarter ($1.9M vs $517.0K). Over the past eight quarters, Planet Labs PBC's revenue compounded faster (17.5% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Planet Labs PBC, known as "Planet.", is a publicly traded American Earth imaging company based in San Francisco, California. Their goal is to image the entirety of the Earth daily to monitor changes and pinpoint trends.

CLB vs PL — Head-to-Head

Bigger by revenue
CLB
CLB
1.5× larger
CLB
$121.8M
$81.3M
PL
Growing faster (revenue YoY)
PL
PL
+34.1% gap
PL
32.6%
-1.4%
CLB
Higher net margin
CLB
CLB
77.1% more per $
CLB
4.2%
-72.8%
PL
More free cash flow
PL
PL
$1.4M more FCF
PL
$1.9M
$517.0K
CLB
Faster 2-yr revenue CAGR
PL
PL
Annualised
PL
17.5%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q3 FY2026

Metric
CLB
CLB
PL
PL
Revenue
$121.8M
$81.3M
Net Profit
$5.1M
$-59.2M
Gross Margin
57.3%
Operating Margin
1.5%
-22.6%
Net Margin
4.2%
-72.8%
Revenue YoY
-1.4%
32.6%
Net Profit YoY
-194.7%
EPS (diluted)
$0.11
$-0.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
PL
PL
Q1 26
$121.8M
Q4 25
$138.3M
$81.3M
Q3 25
$134.5M
$73.4M
Q2 25
$130.2M
$66.3M
Q1 25
$123.6M
$61.6M
Q4 24
$129.2M
$61.3M
Q3 24
$134.4M
$61.1M
Q2 24
$130.6M
$60.4M
Net Profit
CLB
CLB
PL
PL
Q1 26
$5.1M
Q4 25
$4.9M
$-59.2M
Q3 25
$14.2M
$-22.6M
Q2 25
$10.6M
$-12.6M
Q1 25
$-154.0K
$-35.2M
Q4 24
$7.4M
$-20.1M
Q3 24
$11.7M
$-38.7M
Q2 24
$9.0M
$-29.3M
Gross Margin
CLB
CLB
PL
PL
Q1 26
Q4 25
20.8%
57.3%
Q3 25
22.0%
57.6%
Q2 25
20.3%
55.2%
Q1 25
19.5%
62.1%
Q4 24
17.8%
61.2%
Q3 24
20.5%
52.9%
Q2 24
21.2%
52.4%
Operating Margin
CLB
CLB
PL
PL
Q1 26
1.5%
Q4 25
11.5%
-22.6%
Q3 25
15.6%
-24.5%
Q2 25
11.7%
-34.4%
Q1 25
3.6%
-31.5%
Q4 24
11.0%
-36.9%
Q3 24
14.7%
-64.8%
Q2 24
12.3%
-57.2%
Net Margin
CLB
CLB
PL
PL
Q1 26
4.2%
Q4 25
3.6%
-72.8%
Q3 25
10.6%
-30.8%
Q2 25
8.2%
-19.1%
Q1 25
-0.1%
-57.1%
Q4 24
5.7%
-32.8%
Q3 24
8.7%
-63.3%
Q2 24
6.9%
-48.5%
EPS (diluted)
CLB
CLB
PL
PL
Q1 26
$0.11
Q4 25
$0.11
$-0.19
Q3 25
$0.30
$-0.07
Q2 25
$0.22
$-0.04
Q1 25
$0.00
$-0.12
Q4 24
$0.15
$-0.07
Q3 24
$0.25
$-0.13
Q2 24
$0.19
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
PL
PL
Cash + ST InvestmentsLiquidity on hand
$22.8M
$443.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$275.1M
$349.6M
Total Assets
$587.7M
$1.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
PL
PL
Q1 26
$22.8M
Q4 25
$22.7M
$443.3M
Q3 25
$25.6M
$181.1M
Q2 25
$31.2M
$133.5M
Q1 25
$22.1M
$118.0M
Q4 24
$19.2M
$139.0M
Q3 24
$21.5M
$148.3M
Q2 24
$17.7M
$107.4M
Total Debt
CLB
CLB
PL
PL
Q1 26
Q4 25
$110.3M
Q3 25
$114.1M
Q2 25
$124.6M
Q1 25
$124.4M
Q4 24
$126.1M
Q3 24
$139.9M
Q2 24
$147.6M
Stockholders' Equity
CLB
CLB
PL
PL
Q1 26
$275.1M
Q4 25
$266.0M
$349.6M
Q3 25
$271.3M
$435.7M
Q2 25
$261.3M
$444.8M
Q1 25
$253.4M
$441.3M
Q4 24
$246.6M
$464.6M
Q3 24
$250.7M
$473.2M
Q2 24
$240.3M
$500.3M
Total Assets
CLB
CLB
PL
PL
Q1 26
$587.7M
Q4 25
$584.0M
$1.1B
Q3 25
$591.4M
$696.4M
Q2 25
$602.1M
$658.4M
Q1 25
$591.5M
$633.8M
Q4 24
$585.1M
$630.8M
Q3 24
$600.5M
$658.4M
Q2 24
$597.8M
$674.6M
Debt / Equity
CLB
CLB
PL
PL
Q1 26
Q4 25
0.41×
Q3 25
0.42×
Q2 25
0.48×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.56×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
PL
PL
Operating Cash FlowLast quarter
$4.0M
$28.6M
Free Cash FlowOCF − Capex
$517.0K
$1.9M
FCF MarginFCF / Revenue
0.4%
2.3%
Capex IntensityCapex / Revenue
32.9%
Cash ConversionOCF / Net Profit
0.77×
TTM Free Cash FlowTrailing 4 quarters
$22.5M
$40.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
PL
PL
Q1 26
$4.0M
Q4 25
$7.9M
$28.6M
Q3 25
$8.5M
$67.8M
Q2 25
$13.9M
$17.3M
Q1 25
$6.7M
$-6.3M
Q4 24
$20.6M
$4.1M
Q3 24
$13.1M
$-7.9M
Q2 24
$17.1M
$-4.3M
Free Cash Flow
CLB
CLB
PL
PL
Q1 26
$517.0K
Q4 25
$5.0M
$1.9M
Q3 25
$6.5M
$47.5M
Q2 25
$10.4M
$9.2M
Q1 25
$3.9M
$-17.9M
Q4 24
$17.4M
$-3.6M
Q3 24
$10.4M
$-23.0M
Q2 24
$14.3M
$-14.2M
FCF Margin
CLB
CLB
PL
PL
Q1 26
0.4%
Q4 25
3.6%
2.3%
Q3 25
4.8%
64.7%
Q2 25
8.0%
13.9%
Q1 25
3.1%
-29.1%
Q4 24
13.4%
-5.8%
Q3 24
7.7%
-37.6%
Q2 24
10.9%
-23.6%
Capex Intensity
CLB
CLB
PL
PL
Q1 26
Q4 25
2.1%
32.9%
Q3 25
1.5%
27.6%
Q2 25
2.7%
12.3%
Q1 25
2.3%
18.9%
Q4 24
2.5%
12.5%
Q3 24
2.0%
24.8%
Q2 24
2.2%
16.4%
Cash Conversion
CLB
CLB
PL
PL
Q1 26
0.77×
Q4 25
1.61×
Q3 25
0.60×
Q2 25
1.31×
Q1 25
Q4 24
2.78×
Q3 24
1.12×
Q2 24
1.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLB
CLB

Segment breakdown not available.

PL
PL

Defense And Intelligence$49.4M61%
Civil Government$18.8M23%
Commercial$13.1M16%

Related Comparisons